Specific IgG subclass antibody in rubella virus infections

Area of Science:

• Immunology
• Virology
• Diagnostic Assay Development

Background:

• Rubella virus infection elicits a complex antibody response involving IgG subclasses.
• Accurate differentiation between primary rubella infection and reinfection is clinically significant for immune status assessment.
• Existing serological methods may have limitations in precisely characterizing rubella-specific antibody responses.

Purpose of the Study:

• To develop and validate a solid-phase antigen enzyme-linked immunosorbent assay (ELISA) for quantifying rubella-specific IgG subclasses (IgG1 and IgG3).
• To assess the utility of the developed ELISA in distinguishing primary rubella from rubella reinfection.
• To evaluate the antibody response following rubella vaccination.

Main Methods:

• Development of a solid-phase antigen ELISA for rubella-specific IgG1 and IgG3 detection.
• Quantitation of IgG subclasses in arbitrary units (au) using standard curves.
• Validation of the assay using sera from individuals with primary rubella, rubella reinfection, rubella vaccination, and rubella-negative controls.
• Comparison with established serological methods like radial haemolysis (RH) and latex agglutination (LA).

Main Results:

• The ELISA successfully quantitated rubella-specific IgG1 and IgG3.
• IgG1 was detected in all past rubella cases and primary infections by day 8.
• IgG3 was detected in primary rubella cases by day 16 and in some reinfection cases, aiding in differentiating primary infection from reinfection in asymptomatic individuals.
• Post-vaccination sera showed high levels of IgG1 and lower levels of IgG3.

Conclusions:

• The developed ELISA is a sensitive tool for detecting rubella-specific IgG1 and IgG3.
• The assay can differentiate between primary rubella infection and reinfection, particularly in asymptomatic cases.
• The findings provide insights into the dynamics of IgG subclass responses post-infection and vaccination.